Propel Bio Management »

Oculis Holding shares owned by Propel Bio Management

Quarter-by-quarter ownership of Oculis Holding (OCS) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Oculis Holding

Tip: Access up to 7 years of quarterly data

All positions including Oculis Holding held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oculis Holding by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.5M 173k 19.97

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Miragen Therapeutics (VRDN)
Milestone Pharmaceuticals (MIST)
Kyverna Therapeutics (KYTX)
Compass Pathways Sponsored Ads (CMPS)
Inventiva Sa - Ads (IVA)
Delcath Systems Com New (DCTH)
Abeona Therapeutics Com New (ABEO)
Celldex Therapeutics Com New (CLDX)
Nektar Therapeutics Com New (NKTR)
Oculis Holding Ordinary Shares (OCS)
Sab Biotherapeutics Com New (SABS)
Regenxbio Inc equity us cm (RGNX)

View all positions for Propel Bio Management

Top funds holding Oculis Holding

EQT Fund Management S.a r.l.
Gildi - lifeyrissjodur
Pivotal bioVenture Partners Investment Advisor
Standard Life Aberdeen
Sr One Capital Management
Saturn V Capital Management
Nan Fung Group Holdings
Alyeska Investment Group
Woodline Partners
Syquant Capital Sas
Folketrygdfondet
Propel Bio Management
Compagnie Lombard, Odier SCA
Longwood Capital Partners
Simplify Asset Management

View all funds holding Oculis Holding